-
Ebp1 p48 Promotes Oncogenic Properties in Non-Small Cell Lung Cancer Through PI3K/Akt Signaling Pathways
22 Sep 2025 13:16 GMT
… survival rate of 23%.2 Non-small cell lung cancer (NSCLC) is the most prevalent … method for diagnosing and treating non-small cell lung cancer (NSCLC), it is essential to … effect of Ebp1 p48 in non-small cell lung cancer (NSCLC) and its molecular mechanism. …
-
Kelun-Biotech's New Drug Application for Its Novel Next-generation Selective RET Inhibitor A400/EP0031 Accepted for Review by the NMPA for the Treatment of RET-fusion positive NSCLC
23 Sep 2025 04:55 GMT
… locally advanced, or metastatic non-small cell lung cancer (NSCLC). This acceptance for review … positive locally advanced, or metastatic NSCLC, respectively. Primary efficacy endpoints … driver mutation types in NSCLC. In Chinese NSCLC patients, the incidence …
-
Huons secures rights to Therapex’s targeted NSCLC therapy, TRX-211
23 Sep 2025 02:19 GMT
Huons has added a non-small cell lung cancer (NSCLC)-targeted anticancer agent … anticancer drug candidate for NSCLC, TRX-211, on … exon 20 insertion-mutant NSCLC. Therapex presented the preclinical … lung cancer (SCLC) and NSCLC based on pathological criteria, …
-
<![CDATA[Long-Term Efficacy of Cemiplimab Encourages Flexibility When Treating NSCLC: Ana Baramidze, MD]]>
22 Sep 2025 22:57 GMT
… non–small cell lung cancer (NSCLC).
This transcript has been lightly …
-
<![CDATA[NSCLC Armamentarium Reaches JAK2 Inhibitors]]>
22 Sep 2025 18:11 GMT
… and atezolizumab in metastatic non-small cell lung cancer (NSCLC) progressed on first-line … patients with metastatic non-small cell lung cancer and secondary resistance … with advanced immunotherapy-treated non-small cell lung cancer (NSCLC). J Clin Oncol. …
-
<![CDATA[Overview of Frontline EGFR+ NSCLC, Including MARIPOSA Survival Benefit]]>
22 Sep 2025 18:11 GMT
… frontline treatment of EGFR-mutated NSCLC. Although osimertinib has long been … the management of EGFR-mutated NSCLC, with more tools now available …
-
Nuvation Bio Receives Approval from Japan's Ministry of Health, Labour and Welfare for IBTROZITM for Patients with Advanced ROS1-positive Non-Small Cell Lung Cancer
19 Sep 2025 14:30 GMT
… and/or recurrent non-small cell lung cancer (NSCLC). As part of an … globally are diagnosed with non-small cell lung cancer (NSCLC), the most common form … advanced or metastatic ROS1+ non-small cell lung cancer (NSCLC). IMPORTANT SAFETY INFORMATION FOR …
-
<![CDATA[Treatment Approaches and Unmet Needs in Second-Line Advanced NSCLC]]>
22 Sep 2025 13:20 GMT
-
<![CDATA[Rationale for Evaluating IB6 as a Potential Therapeutic Target in NSCLC]]>
22 Sep 2025 13:20 GMT
-
Peritoneal Metastasis in Non-Small Cell Lung Cancer: A Systematic Review of Clinical Features, Molecular Profiles, Diagnostic Approaches, and Outcomes
19 Sep 2025 09:19 GMT
Introduction
Non-small cell lung cancer (NSCLC) accounts for … ; NGS, Next-Generation Sequencing; NSCLC, Non-Small Cell Lung Cancer; OS, Overall Survival; PC … ) of EGFR mutation-positive non-small cell lung cancer (NSCLC) patients: real-world treatment …
About
© 1995-2025